-
-
-
-
-
-
-
Bristol Myers Squibb gains EU approval for Opdivo combination in lymphoma
-
-
-
-
-
-
-
BMO Capital Reiterates Market Perform Rating on Bristol-Myers Squibb Co. (BMY)
-
-
-
-
-
-
-
Atrium Therapeutics receives $15 million milestone from Bristol Myers Squibb
-
-
-
-
-
-
-
Bristol Myers Squibb study shows stable symptom transition to COBENFY
-
-
-
-
-
-
-
Bristol-Myers Squibb Co. (BMY) PT Raised to $70 at UBS Ahead of Major Catalyst
-
-
-
-
-
-
-
FDA accepts Bristol Myers Squibb drug application for multiple myeloma
-
-
-
-
-
-
-
Stocks expected to have increasing option volume: BMY KKR CMI CI CBOE CARR CAH EL HSY TPR RL PTON AMZN MSTR BIIB ALGT MOD M KLIC HP
-
419,028 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

